KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 04-30. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 100M 200M 300M FY10: 99.1M FY11: 100M FY12: 102.8M FY13: 117.1M FY14: 111.2M FY15: 118.8M FY16: 128.6M FY16: 128.6M FY17: 138.6M FY18: 158.1M FY19: 146.6M FY20: 147.5M FY21: 147.5M FY22: 168.9M FY23: 219.5M FY24: 203.8M FY25: 240.5M FY26: 282M FY11 FY13 FY15 FY16 FY18 FY20 FY22 FY24 FY26

Gross Profit Annual

0 30M 60M 90M FY10: 21.4M FY11: 19.3M FY12: 19.2M FY13: 22.3M FY14: 22M FY15: 21.8M FY16: 23.7M FY16: 23.7M FY17: 26.6M FY18: 32.2M FY19: 25.3M FY20: 23.4M FY21: 24M FY22: 24.2M FY23: 35.6M FY24: 52.1M FY25: 68.9M FY26: 80.4M FY11 FY13 FY15 FY16 FY18 FY20 FY22 FY24 FY26

Operating Income Annual

-7M 0 7M 14M 21M FY10: 5.8M FY11: 3.2M FY12: 2.7M FY13: 5.3M FY14: 6M FY15: 5.2M FY16: 5.7M FY16: 5.7M FY17: 6.5M FY18: 9.9M FY19: 2.1M FY20: -2.3M FY21: -1.3M FY22: -2.6M FY23: 5.4M FY24: 18.3M FY25: 17.8M FY26: 16.7M FY11 FY13 FY15 FY16 FY18 FY20 FY22 FY24 FY26

Net Income Annual

-7M 0 7M 14M 21M FY10: 3.6M FY11: 1.9M FY12: 1M FY13: 3M FY14: 3.9M FY15: 3.5M FY16: 3.8M FY16: 3.8M FY17: 4.5M FY18: 5.3M FY19: 1.5M FY20: -4.7M FY21: -3.7M FY22: -6.1M FY23: 738K FY24: 18.8M FY25: 11.4M FY26: 9.6M FY11 FY13 FY15 FY16 FY18 FY20 FY22 FY24 FY26

Cost of Revenue Annual

0 70M 140M 210M FY16: 104.9M FY17: 112M FY18: 125.9M FY19: 121.2M FY20: 124.1M FY21: 123.5M FY22: 144.7M FY23: 183.9M FY24: 151.7M FY25: 171.6M FY26: 201.6M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Operating Cash Flow Annual

-14M -7M 0 7M 14M 21M FY10: 4.5M FY11: 1.3M FY12: 6.9M FY13: 3.8M FY14: 8.1M FY15: 2.3M FY16: 7.3M FY16: 7.3M FY17: 11.7M FY18: 3.2M FY19: 2.5M FY20: 4.2M FY21: 912K FY22: -7.9M FY23: -3.8M FY24: 19.6M FY25: 14.8M FY26: 18.6M FY11 FY13 FY15 FY16 FY18 FY20 FY22 FY24 FY26

Free Cash Flow Annual

-12M -6M 0 6M 12M 18M FY10: 294K FY11: -4M FY12: 5.5M FY13: 1.4M FY14: 6M FY15: -277K FY16: 5.1M FY16: 5.1M FY17: 9.1M FY18: -212K FY19: -1.7M FY20: 1.7M FY21: -1.5M FY22: -9.8M FY23: -7.9M FY24: 15.2M FY25: 12.6M FY26: 14.7M FY11 FY13 FY15 FY16 FY18 FY20 FY22 FY24 FY26

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 1.5M 3M 4.5M FY10: 2.6M FY11: 2.6M FY12: 2.6M FY13: 2.6M FY14: 2.6M FY15: 2.7M FY16: 2.7M FY16: 2.7M FY17: 2.7M FY18: 2.8M FY19: 2.8M FY20: 2.8M FY21: 2.8M FY22: 2.8M FY23: 2.9M FY24: 2.9M FY25: 3M FY26: 3M FY11 FY13 FY15 FY16 FY18 FY20 FY22 FY24 FY26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-5.00 -2.50 0.00 2.50 5.00 7.50 Q4 '11: 0.71 Q1 '12: 0.47 Q2 '12: 0.09 Q3 '12: 0.01 Q4 '12: 0.40 Q1 '13: 0.64 Q2 '13: 0.94 Q3 '13: 1.20 Q4 '13: 1.17 Q1 '14: 1.53 Q2 '14: 1.56 Q3 '14: 1.57 Q4 '14: 1.48 Q1 '15: 1.34 Q2 '15: 1.51 Q3 '15: 1.47 Q4 '15: 1.33 Q1 '16: 1.21 Q2 '16: 1.02 Q3 '16: 1.15 Q4 '16: 1.42 Q1 '17: 1.55 Q2 '17: 1.83 Q3 '17: 1.65 Q4 '17: 1.66 Q1 '18: 1.60 Q2 '18: 1.68 Q3 '18: 1.87 Q4 '18: 1.92 Q1 '19: 2.03 Q2 '19: 1.89 Q3 '19: 1.56 Q4 '19: 0.54 Q1 '20: 0.18 Q2 '20: -1.09 Q3 '20: -1.78 Q4 '20: -1.71 Q1 '21: -2.10 Q2 '21: -1.38 Q3 '21: -0.65 Q4 '21: -1.34 Q1 '22: -1.60 Q2 '22: -2.64 Q3 '22: -3.14 Q4 '22: -2.19 Q1 '23: -1.98 Q2 '23: -0.96 Q3 '23: -0.24 Q4 '23: 0.25 Q1 '24: 1.38 Q2 '24: 2.40 Q3 '24: 3.00 Q4 '24: 6.38 Q1 '25: 6.26 Q2 '25: 6.34 Q3 '25: 5.94 Q4 '25: 3.83 Q1 '26: 4.13 Q2 '26: 3.94 Q3 '26: 3.72 Q4 '26: 3.22 Q4 '12 Q4 '14 Q4 '16 Q4 '18 Q4 '20 Q4 '22 Q4 '24 Q4 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.